Invion Financial Statements From 2010 to 2024

7C8 Stock  EUR 0.15  0.01  6.25%   
Invion financial statements provide useful quarterly and yearly information to potential Invion Limited investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Invion financial statements helps investors assess Invion's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Invion's valuation are summarized below:
Invion Limited does not presently have any fundamental trends for analysis.
Check Invion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Invion's main balance sheet or income statement drivers, such as , as well as many indicators such as . Invion financial statements analysis is a perfect complement when working with Invion Valuation or Volatility modules.
  
This module can also supplement various Invion Technical models . Check out the analysis of Invion Correlation against competitors.

Invion Limited Company Shares Outstanding Analysis

Invion's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Invion Shares Outstanding

    
  4.21 B  
Most of Invion's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Invion Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Invion Limited has 4.21 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers - Specialty & Generic industry. The shares outstanding for all Germany stocks is significantly lower than that of the firm.

Invion Limited Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Invion's current stock value. Our valuation model uses many indicators to compare Invion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Invion competition to find correlations between indicators driving Invion's intrinsic value. More Info.
Invion Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Invion's earnings, one of the primary drivers of an investment's value.

About Invion Financial Statements

Invion stakeholders use historical fundamental indicators, such as Invion's revenue or net income, to determine how well the company is positioned to perform in the future. Although Invion investors may analyze each financial statement separately, they are all interrelated. For example, changes in Invion's assets and liabilities are reflected in the revenues and expenses on Invion's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Invion Limited. Please read more on our technical analysis and fundamental analysis pages.
Invion Limited, a clinical-stage drug development company, develops treatments for inflammatory diseases in Australia and the United States. It has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers. Invion operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Invion Stock

Invion financial ratios help investors to determine whether Invion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Invion with respect to the benefits of owning Invion security.